NVNO
enVVeno Medical CorpCompany Information
- Company Name
- enVVeno Medical Corp
- CIK
- CIK0001661053
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- NVNO: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- NVNO
SEC filing data through
Insider Sentiment
- Last purchase
- 2024-12-31
- Last sale
- 2026-09-11
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 10,091
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 88,718
- Shares outstanding
- 671,000
- Ownership
- 13.22%
Earnings Market Reaction
- Filing date
- 2026-07-30
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 3 | 3 | 3 | 2 | 2 | 3 | 2 | 18 | 2 | 2 | 4 | 5 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 22 | 25 | 29 | 31 | 36 | 39 | 44 | 49 | 40 | 43 | 47 | 26 | ||||||
| Short Term Investments | 19 | 22 | 25 | 29 | 33 | 36 | 41 | 30 | 37 | 41 | 43 | 21 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Assets | 23 | 26 | 30 | 32 | 37 | 41 | 45 | 50 | 41 | 45 | 49 | 28 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable Current | - | - | - | - | - | - | - | - | - | - | - | 2 | ||||||
| Accounts Payable And Accrued Liabilities Current | - | - | - | 2 | 3 | 1 | 2 | 2 | 1 | 1 | 1 | - | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 2 | ||||||
| Accounts Payable And Other Accrued Liabilities Current | 1 | 2 | 2 | - | - | - | 2 | - | - | - | - | - | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Liabilities | 2 | 2 | 2 | 3 | 4 | 2 | 3 | 3 | 3 | 2 | 2 | 3 | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | 21 | 24 | 27 | 29 | 33 | 38 | 42 | 47 | 38 | 42 | 46 | 25 | ||||||
| Additional Paid In Capital | 199 | 199 | 198 | 197 | 196 | 195 | 194 | 193 | 178 | 177 | 176 | 149 | ||||||
| Retained Earnings Accumulated Deficit | -179 | -175 | -171 | -168 | -163 | -156 | -152 | -146 | -140 | -135 | -130 | -124 | ||||||
| Liabilities And Stockholders Equity | 23 | 26 | 30 | 32 | 37 | 41 | 45 | 50 | 41 | 45 | 49 | 28 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | ||||||
| Common Stock Shares Issued | 1 | 1 | 1 | 20 | 19 | 18 | 1 | 18 | 13 | 13 | 13 | 9 | ||||||
| Shares Outstanding | 1 | 1 | 1 | 20 | 19 | 18 | 1 | 18 | 13 | 13 | 13 | 9 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialenVVeno Medical Corp (NVNO) — SEC Financial Statements & Analysis
enVVeno Medical Corp (NVNO) is a surgical & medical instruments & apparatus company, incorporated in DE. enVVeno Medical Corp trades on Nasdaq as: NVNO. enVVeno Medical Corp (NVNO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-30. Based on that filing, enVVeno Medical Corp carries a market cap of $7.19M, a P/E ratio of -0.46x, a P/B ratio of 0.35x, an enterprise value of $4.35M, and an EV/EBITDA multiple of -0.26x. On profitability, it posts a Return on Equity (ROE) of -58.53%, a Return on Assets (ROA) of -53.09%, and a Return on Invested Capital (ROIC) of -68.60%. Per share, it reports EPS of $-23.43, diluted EPS of $-23.43, free cash flow per share of $-21.79, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -31.84% year-over-year and EPS growth of -40.98% year-over-year. On the balance sheet, it maintains a current ratio of 11.70x, a quick ratio of 11.39x, working capital of $20.20M, a debt-to-equity ratio of 0.10x, a debt ratio of 0.09, free cash flow of $-14.62M (TTM), and net debt of $-2.84M. Figures sourced from SEC EDGAR.
- Market Cap
- $7.19M
- P/E TTM
- -0.46x
- EPS TTM
- $-23.43
- P/B TTM
- 0.35x
- ROE TTM
- -58.53%
- ROA TTM
- -53.09%
- Debt To Equity
- 0.10x
- Free Cash Flow TTM
- $-14.62M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is enVVeno Medical Corp in?
enVVeno Medical Corp (NVNO) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does NVNO trade on?
enVVeno Medical Corp (NVNO) trades on the Nasdaq.
Where is enVVeno Medical Corp incorporated?
enVVeno Medical Corp is incorporated in DE.
When was enVVeno Medical Corp (NVNO)'s most recent SEC filing?
enVVeno Medical Corp (NVNO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-30.
What is NVNO's market cap?
enVVeno Medical Corp (NVNO) has a market capitalization of $7.19M as of 2026-06-30.
What is NVNO's EPS (earnings per share)?
enVVeno Medical Corp (NVNO)'s trailing twelve month EPS is $-23.43 as of 2026-06-30.
What is NVNO's ROE (return on equity)?
enVVeno Medical Corp (NVNO)'s trailing twelve month Return on Equity (ROE) is -58.53% as of 2026-06-30.
What is NVNO's ROA (return on assets)?
enVVeno Medical Corp (NVNO)'s trailing twelve month Return on Assets (ROA) is -53.09% as of 2026-06-30.
What is NVNO's ROIC (return on invested capital)?
enVVeno Medical Corp (NVNO)'s trailing twelve month Return on Invested Capital (ROIC) is -68.60% as of 2026-06-30.
What is NVNO's EV/EBITDA?
enVVeno Medical Corp (NVNO)'s trailing twelve month EV/EBITDA is -0.26x as of 2026-06-30.